HPS Pharmacies wish to give notice that Accord Healthcare, in consultation with the Therapeutic Goods Administration (TGA), has initiated a drug recall for Aciclovir ACCORD 500 mg/ 20mL injection vials as follows:
Aciclovir 500 mg/ 20mL injection vials
ARTG 313549
The only batch affected by this drug recall are:
- M2313158 (Exp: 03/2025)
This drug recall was initiated due to Batch No. M2313158 possibly containing a glass particle contaminant within the vial solution. This problem was reported by the manufacturer after inspection of retention samples.
Please inspect your stock and quarantine all affected products. If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect all stock stored in the designated imprest areas at the earliest opportunity. All affected products will be quarantined for return to the supplier, and HPS Pharmacies will arrange for replacement stock as soon as possible. An HPS Pharmacies staff member will contact senior medical and nursing staff if there is an immediate impact to your facility.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Accord Healthcare on 1800 222 673 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates